JPH04211013A - スティグマスタ−４−エン−３−オンを含む薬剤およびその用途 - Google Patents

スティグマスタ−４−エン−３−オンを含む薬剤およびその用途

Info

Publication number
JPH04211013A
JPH04211013A JP3020960A JP2096091A JPH04211013A JP H04211013 A JPH04211013 A JP H04211013A JP 3020960 A JP3020960 A JP 3020960A JP 2096091 A JP2096091 A JP 2096091A JP H04211013 A JPH04211013 A JP H04211013A
Authority
JP
Japan
Prior art keywords
stigmaster
testosterone
androgen
treatment
drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3020960A
Other languages
English (en)
Japanese (ja)
Inventor
August S Streber
アウグスト　エス　ストレーバー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kanoldt Arzneimittel GmbH
Original Assignee
Kanoldt Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanoldt Arzneimittel GmbH filed Critical Kanoldt Arzneimittel GmbH
Publication of JPH04211013A publication Critical patent/JPH04211013A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
JP3020960A 1990-02-16 1991-02-14 スティグマスタ−４−エン−３−オンを含む薬剤およびその用途 Pending JPH04211013A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4004920 1990-02-16
DE4004920A DE4004920C1 (enExample) 1990-02-16 1990-02-16

Publications (1)

Publication Number Publication Date
JPH04211013A true JPH04211013A (ja) 1992-08-03

Family

ID=6400348

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3020960A Pending JPH04211013A (ja) 1990-02-16 1991-02-14 スティグマスタ−４−エン−３−オンを含む薬剤およびその用途

Country Status (4)

Country Link
EP (1) EP0442350B1 (enExample)
JP (1) JPH04211013A (enExample)
AT (1) ATE106732T1 (enExample)
DE (2) DE4004920C1 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005330228A (ja) * 2004-05-20 2005-12-02 Pias Arise Kk 毛成長抑制剤、並びにその毛成長抑制剤を配合した皮膚外用剤及び化粧料
JP2006519819A (ja) * 2003-03-11 2006-08-31 トロフォ コレスト−４−エン−３−オンの誘導体の医薬としての使用、これらを含む医薬組成物、新規誘導体及びそれらの製造方法
JP2007197387A (ja) * 2006-01-27 2007-08-09 Maruzen Pharmaceut Co Ltd テストステロン５α−レダクターゼ阻害剤

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3873097B2 (ja) * 1997-11-06 2007-01-24 独立行政法人理化学研究所 抗肥満剤及び脂質代謝改善剤
US6531462B2 (en) 1997-11-06 2003-03-11 Riken Medicament for treating obesity and improving lipid metabolism
US6677327B1 (en) * 1999-11-24 2004-01-13 Archer-Daniels-Midland Company Phytosterol and phytostanol compositions

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6114811A (ja) * 1984-05-21 1986-01-23 Mitsubishi Heavy Ind Ltd 帯板の側端部切削方法
JPS61148196A (ja) * 1984-12-21 1986-07-05 Ichimaru Fuarukosu Kk 新規ステロイド化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3401178A1 (de) * 1984-01-14 1985-07-18 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen Verwendung von phytosterolglykosiden zur behandlung erhoehter 5(6)(alpha)-epoxicholesterolspiegel
DE3827953A1 (de) * 1988-08-17 1990-02-22 Kanoldt Arzneimittel Gmbh Arzneimittelzubereitung aus einem extrakt der brennesselwurzel urtica kiovensis (rogowicz), dessen verwendung zur behandlung von geschwulsten und herstellverfahren

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6114811A (ja) * 1984-05-21 1986-01-23 Mitsubishi Heavy Ind Ltd 帯板の側端部切削方法
JPS61148196A (ja) * 1984-12-21 1986-07-05 Ichimaru Fuarukosu Kk 新規ステロイド化合物

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006519819A (ja) * 2003-03-11 2006-08-31 トロフォ コレスト−４−エン−３−オンの誘導体の医薬としての使用、これらを含む医薬組成物、新規誘導体及びそれらの製造方法
JP2005330228A (ja) * 2004-05-20 2005-12-02 Pias Arise Kk 毛成長抑制剤、並びにその毛成長抑制剤を配合した皮膚外用剤及び化粧料
JP2007197387A (ja) * 2006-01-27 2007-08-09 Maruzen Pharmaceut Co Ltd テストステロン５α−レダクターゼ阻害剤

Also Published As

Publication number Publication date
DE4004920C1 (enExample) 1991-09-19
ATE106732T1 (de) 1994-06-15
EP0442350B1 (de) 1994-06-08
EP0442350A1 (de) 1991-08-21
DE59101818D1 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
AU1210695A (en) Use of aldosterone antagonists to inhibit myocardial fibrosis
MXPA01009879A (es) Uso de extracto de serenoa repens para la produccion de un medicamento para tratar cancer de prostata.
MXPA04006057A (es) Productos farmaceuticos orales que contienen 3-alcanoato inferior de 17-beta-estradiol, metodo para administrar los mismos y proceso de preparacion.
US5708038A (en) Method of using aloe vera as a biological vehicle
NO341780B1 (no) Testosterongeler omfattende polypropylenglykol og isopropylmyristat som gjennomtrengningsforsterker
JP2001500500A (ja) 前立腺肥大及び前立腺癌を治療する手段
JPH0150206B2 (enExample)
KR20010075621A (ko) 에스트로겐의 에난티오머를 사용한 허혈성 손상으로부터의세포 보호 방법
Ip et al. Functionality of estrogen receptor and tamoxifen treatment of R3327 Dunning rat prostate adenocarcinoma
US5264428A (en) Use of stigmasta-4-en-3-one in the treatment of androgen dependent diseases
Goldspiel et al. Goserelin acetate implant: a depot luteinizing hormone-releasing hormone analog for advanced prostate cancer
EP1854465A1 (en) Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers
JPH01301623A (ja) にきびまたはアンドロゲン性脱毛の局所治療のためのエチステロンの使用
JP2007528361A (ja) 前立腺障害の治療および予防のための生薬組成物
EP0442350B1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung
EP3746047A1 (en) Injectable composition
CN105982882B (zh) 一种光学活性原料组合物组方治疗痔疮的外用药及制备工艺
US6008210A (en) Use of aldosterone antagonists to inhibit myocardial fibrosis
FR2987264A1 (fr) Methodes et compositions pour le traitement des metastases cancereuses
CZ200377A3 (cs) 7-Hydroxyepiandrosteron s neuroprotektivním účinkem
RU2812129C1 (ru) Гормональное средство для регуляции половой охоты у мелких домашних животных
RU2589266C1 (ru) Фармацевтическая композиция для лечения злокачественных новообразований предстательной железы
US6613758B1 (en) Method for treating osteoporosis in castrated prostatic cancer patients
CN102218106B (zh) 一种治疗肝肾不足的中药组合物及其制备方法
Mansour et al. Prostatech: A Botanical Ozonated Oil Composition for Enlarged Prostate and Prostate Cancer

Legal Events

Date Code Title Description
A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 19941206